Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III IMpower130 study of Tecentriq in NSCLC meets coprimary endpoints

May 29, 2018

Pfizer seeks Japanese approval of dacomitinib for EGFR mutation-positive NSCLC

May 29, 2018

Researchers discover new targets for lymphoblastic leukemia immunotherapy

May 29, 2018

Kowa to launch Parmodia in Japan for hyperlipidemia

May 29, 2018

Japanese approval sought for Trelegy Ellipta

May 29, 2018

Chugai seeks Japanese approval for Actemra for cytokine release syndrome

May 29, 2018

REXGEX trial shows importance of immune status for enhanced efficacy with CetuGEX

May 29, 2018

FDA grants priority review for gilteritinib NDA in relapsed or refractory AML

May 29, 2018

IDMC recommends continuation of phase III study of Zepsyre in small cell lung cancer

May 29, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...